Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter Observational Open Program. Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril in Patients With Arterial Hypertension and Stable CAD in Daily Clinical Practice (STYLE)

Next Previous
Trial Profile

Multicenter Observational Open Program. Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril in Patients With Arterial Hypertension and Stable CAD in Daily Clinical Practice (STYLE)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bisoprolol/perindopril (Primary)
  • Indications Angina pectoris; Coronary artery disease; Essential hypertension
  • Focus Therapeutic Use
  • Acronyms STYLE
  • Sponsors Servier Russia

    • Most Recent Events

    • 20 Jun 2022 Results of a post hoc analysis assessed the safety and efficacy of Bis/ Per SPC in the subgroup with a history of Myocardial Infarction presented at the 31st European meeting on hypertension and cardiovascular protection
    • 15 May 2021 Primary endpoint (The Mean SBP Changes (mm Hg) at the Visit 3 vs. Baseline) , has been met according to Results published in the Advances in Therapy
    • 15 May 2021 Results published in the Advances in Therapy
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top